- Report
- June 2023
- 186 Pages
Global
From €5317EUR$5,500USD£4,567GBP
- Report
- March 2024
- 191 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- March 2024
- 196 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- September 2023
- 140 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- April 2024
- 92 Pages
Global
From €5414EUR$5,600USD£4,650GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- September 2023
- 190 Pages
Global
From €2407EUR$2,490USD£2,068GBP
- Report
- January 2024
- 215 Pages
Global
From €7686EUR$7,950USD£6,602GBP
- Report
- March 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- September 2022
- 377 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- November 2021
- 261 Pages
Global
From €5076EUR$5,250USD£4,360GBP
- Report
- May 2021
- 208 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- December 2021
- 108 Pages
Global
From €2659EUR$2,750USD£2,284GBP
€5317EUR$5,500USD£4,567GBP
- Report
- March 2023
- 150 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- March 2023
- 356 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- April 2023
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
Kidney cancer, also known as renal cancer, is a type of cancer that originates in the kidneys. It is one of the most common types of cancer in adults, and is typically diagnosed in individuals over the age of 50. Symptoms of kidney cancer can include blood in the urine, pain in the side or lower back, and a lump in the abdomen. Treatment options for kidney cancer include surgery, radiation therapy, and chemotherapy.
In the oncology market, kidney cancer is a major area of focus for drug development. Pharmaceutical companies are researching and developing new treatments to improve outcomes for patients with kidney cancer. These treatments include targeted therapies, immunotherapies, and combination therapies.
Some companies in the kidney cancer market include Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Novartis. Show Less Read more